{"article_title": "Will The Affordable Care Act Give Drugmakers A Boost?", "article_keywords": ["affordable", "drugmakers", "boost", "act", "care"], "article_url": "http://www.forbes.com/sites/edsilverman/2013/12/26/will-the-affordable-care-act-give-drugmakers-a-boost/", "article_text": "", "article_metadata": {"description": "Will Obamacare really help the pharmaceutical industry? A new forecast from the the Center for Medicare & Medicaid Services offers a rosy projection - spending should grow significantly next year, thanks to greater use among Americans who are newly insured or those sign up for accessible insurance plans. Of course, this assumes enrollment targets are met.", "author": "Ed Silverman", "og": {"site_name": "Forbes", "description": "Will Obamacare really help the pharmaceutical industry? A new forecast from the the Center for Medicare & Medicaid Services offers a rosy projection - spending should grow significantly next year, thanks to greater use among Americans who are newly insured or those sign up for accessible insurance plans. Of course, this assumes enrollment targets are met.", "title": "Will The Affordable Care Act Give Drugmakers A Boost?", "url": "http://www.forbes.com/sites/edsilverman/2013/12/26/will-the-affordable-care-act-give-drugmakers-a-boost/", "image": "http://b-i.forbesimg.com/edsilverman/files/2013/12/4212028896_3f3751b06d_s.jpg", "updated_time": "2013-12-27T00:22:54-05:00", "type": "article"}, "twitter": {"description": "Will Obamacare really help the pharmaceutical industry? A new forecast from the the Center for Medicare & Medicaid Services offers a rosy projection - spending should grow significantly next year, thanks to greater use among Americans who are newly insured or those sign up for accessible insurance plans. Of course, this assumes enrollment targets are met.", "creator": "@pharmalot", "image": "http://b-i.forbesimg.com/edsilverman/files/2013/12/4212028896_3f3751b06d_s.jpg", "title": "Will The Affordable Care Act Give Drugmakers A Boost?", "site": "@forbes", "card": "summary_large_image"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Business,Pharma and Health,Pharma &amp; Healthcare,Affordable Care Act,CMS,Health Care Reform,Medicaid,Medicare,Medicare Part D,Obamacare,Prescription drug,United States", "article": {"publisher": "https://www.facebook.com/forbes", "author": "http://www.facebook.com/MyPharmalot", "section_url": "http://www.forbes.com/business", "section": "Business", "modified": "2013-12-27", "published": "2013-12-26", "id": "blogAndPostId/blog/post/1683-1816"}, "news_keywords": "Business,Pharma and Health,Pharma &amp; Healthcare,Affordable Care Act,CMS,Health Care Reform,Medicaid,Medicare,Medicare Part D,Obamacare,Prescription drug,United States", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "prerender-status-code": "{{meta.code}}"}, "_id": "\"57477af36914bd0286fd192a\"", "article_summary": ""}